Cognitive dysfunction in Nigerians with Parkinson's disease

Movement Disorders

Volumn 23, Issue 10, 2008, Pages 1378-1383

  Akinyemi, Rufus O ^a,b   Okubadejo, Njideka N ^c   Akinyemi, Joshua O ^d   Owolabi, Mayowa O ^b   Owolabi, Lukman F ^b   Ogunniyi, Adesola ^b  

^a FEDERAL MEDICAL CENTER   (Nigeria)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^d UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Africans; Cognitive dysfunction; Nigerians; Parkinson's disease

Indexed keywords

BROMOCRIPTINE; CARBIDOPA; LEVODOPA; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; LANGUAGE DISABILITY; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL PERFORMANCE; MOTOR DYSFUNCTION; NEUROPSYCHOLOGICAL TEST; NIGERIA; ONSET AGE; PARKINSON DISEASE; PREDICTION; PREVALENCE; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE;

ADULT; AGE FACTORS; AGE OF ONSET; AGED; AGED, 80 AND OVER; COGNITION DISORDERS; FEMALE; HUMANS; HYPOKINESIA; LANGUAGE TESTS; MALE; MIDDLE AGED; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; NIGERIA; PARKINSON DISEASE; PREFRONTAL CORTEX; TREMOR;

EID: 52649094385     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22087     Document Type: Article

References (43)

1. Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely and Jones; 1817. p 1-66.
2. Lees AJ, Smith E. Cognitive deficits in the early stage of Parkinson's disease. Brain 1983;106:257-270.
3. Brown MG, Marsden CD. How common is dementia in Parkinson's disease? Lancet 1984;11:262-265.
4. Lang AE, Lozano AM. Parkinson's disease. 1st of two parts. N Engl J Med 1998;339:1044-1053.
5. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312.
6. Okubadejo NU, Ojini FI, Danesi MA. Longitudinal study of mortality predictors in Parkinson's disease in Nigerians. Afr J Med Med Sci 2005;34:365-369.
7. Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003;2:229-237.
8. Foltynie T, Brayne CE, Robbins TW, Barker RA. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN Study. Brain 2004;127:550-560.
9. Muslimovic D, Post B, Speelman JD, Schmand B. Cognitive profile of patients with newly diagnosed Parkinson's disease. Neurology 2005;65:1239-1245.
10. Osuntokun BO, Bademosi O. Parkinsonism in Nigerian Africans: A prospective study of 217 patients. East Afr Med J 1979;56: 597-607.
11. Cummings JL. Intellectual impairment in Parkinson's disease: clinical, pathological and biochemical correlates. J Geriatr Psychiatry Neurol 1988;1:24-36.
12. Levin BE, Tomer R, Rey GJ. Cognitive impairments in Parkinson's disease. Neurol Clin 1992;10:471-485.
13. Salmon DP, Filoteo JV. Neuropsychology of cortical versus subcortical dementia syndromes. Semin Neurol 2007;27:7-21.
14. Zgaljardic DJ, Borod JC, Foldi NC, Mattis P. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to fromostriatal circuitry. Cogn Behav Neurol 2003;16: 193-210.
15. Farina E, Cappa SF, Polimeni M, et al. Frontal dysfunction in early Parkinson's disease. Acta Neurol Scand 1994;90:34-38.
16. Emre M. What causes mental dysfunction in Parkinson's disease? Mov Disord 2003;18 (Suppl 6):S63-S71.
17. Agid Y. Parkinson's disease: pathophysiology. Lancet 1991;337: 1321-1324.
18. Lewis SJ, Dove A, Robbins TW, Barker RA, Owen AM. Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003;23:6351-6356.
19. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 2003;18:467-486.
20. Hall KS, Rodgers DD, Osuntokun BO, et al. The development of a Dementia Screening Interview in two distinct languages. Int J Methods Psych Res 1993;3:1-28.
21. Hall KS, Gao S, Emsley CL, Ogunmyi AO, Morgan O, Hendrie HC. Community Screening Interview for Dementia (CSI 'D'): performance in five disparate study sites. Int J Geriatr Psychiatry 2000;15:521-531.
22. Gureje O, Unverzagt FW, Osuntokun BO, et al. The CERAD Neuropsychological Test Battery: Norms from a Yoruba-speaking Nigerian sample. West Afr J Med 1995;14:29-33.
23. Baddeley A. Working memory. Science 1992;255:556-559.
24. D'Esposito M, Detre JA, Alsop DC, Shin RK, Atlas S, Grossman M. The neural basis of the central executive system of working memory. Nature 1995;378:279-281.
25. Helkala EL, Laulumaa V, Soininen H, Riekkinen PJ. Recall and recognition memory in patients with Alzheimer's and Parkinson's diseases. Ann Neurol 1988;24:214-217.
26. Bayles KA, Trosset MW, Tomoeda CK, Montgomery EB, Jr, Wilson J. Generative naming in Parkinson's disease patients. J Clin Exp Neuropsychol 1993;15:547-562.
27. Peran P, Rascol O, Demonet JF, et al. Deficit of verb generation in non-demented patients with Parkinson's disease. Mov Disord 2003;18:150-156.
28. Starkstein SE, Bolduc PL, Preziosi TJ, Robinson RG. Cognitive impairments in different stages of Parkinson's disease. J Neuropsychiatry Clin Neurosci 1989;1:243-248.
29. Cummings JL. The dementias of Parkinson's disease: prevalence, characteristics, neurobiology and comparison with dementia of the Alzheimer type. Eur J Neurol 1988;28 (Suppl 1):15-23.
30. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
31. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979;205:929-932.
32. Grabowski TJ, Anderson SW, Cooper GE. Disorders of cognitive function. In: Mancall EL, editor. Continuum; life long learning in neurology, Vol. 8. Philadelphia: Lippincott Williams and Wilkins; 2002. p 7-40.
33. Katzen HL, Levin BE, Llabre ML. Age of disease onset influences cognition in Parkinson's disease. J Int Neuropsychol Soc 1998; 4:285-290.
34. Locascio JJ, Corkin S, Growdon JH. Relation between clinical characteristics of Parkinson's disease and cognitive decline. J Clin Exp Neuropsychol 2003;25:94-109.
35. Hughes TA, Ross HF, Musa S, et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000;54:1596-1602.
36. Aarsland D, Kvaløy JT, Andersen K, et al. The effect of age of onset of PD on risk of dementia. J Neurol 2007;254:38-45.
37. Pai MC, Chan SH. Education and cognitive decline in Parkinson's disease: a study of 120 patients. Acta Neurol Scand 2001;103: 243-247.
38. Glatt SL, Hubble JP, Lyons K, et al. Risk factors for dementia in Parkinson's disease: effect of education. Neuroepidemiology 1996; 15:20-25.
39. Green J, McDonald WM, Vitek JL, et al. Cognitive impairment in advanced PD without dementia. Neurology 2002;59:1320-1324.
40. Huber SJ, Paulson GW, Shuttleworth EC. Relationship of motor symptoms, intellectual impairment, and depression in Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:855-858.
41. Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001;62 (Suppl 21):11-14.
42. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
43. Alves G, Larsen JP, Emre M, et al. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Mov Disord 2006;21:1123-1130.